These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 10222418)
1. Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion. Bredel M; Pollack IF; Freund JM; Rusnak J; Lazo JS J Neurooncol; 1999 Jan; 41(1):9-20. PubMed ID: 10222418 [TBL] [Abstract][Full Text] [Related]
2. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor. Pollack IF; Kawecki S; Lazo JS J Neurosurg; 1996 Jun; 84(6):1024-32. PubMed ID: 8847567 [TBL] [Abstract][Full Text] [Related]
3. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53. Shao RG; Shimizu T; Pommier Y Exp Cell Res; 1997 Aug; 234(2):388-97. PubMed ID: 9260909 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Wang Q; Worland PJ; Clark JL; Carlson BA; Sausville EA Cell Growth Differ; 1995 Aug; 6(8):927-36. PubMed ID: 8547221 [TBL] [Abstract][Full Text] [Related]
5. 7-Hydroxystaurosporine-induced apoptosis in 9L glioma cells provides an effective antigen source for dendritic cells and yields a potent vaccine strategy in an intracranial glioma model. Witham TF; Erff ML; Okada H; Chambers WH; Pollack IF Neurosurgery; 2002 Jun; 50(6):1327-34; discussion 1334-5. PubMed ID: 12015852 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1). Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646 [TBL] [Abstract][Full Text] [Related]
7. Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine). Sugiyama K; Akiyama T; Shimizu M; Tamaoki T; Courage C; Gescher A; Akinaga S Cancer Res; 1999 Sep; 59(17):4406-12. PubMed ID: 10485490 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor. Ikemoto H; Tani E; Matsumoto T; Nakano A; Furuyama J J Neurosurg; 1995 Dec; 83(6):1008-16. PubMed ID: 7490614 [TBL] [Abstract][Full Text] [Related]
9. Modulation of apoptosis in rat thymocytes by analogs of staurosporine: lack of direct association with inhibition of protein kinase C. Harkin ST; Cohen GM; Gescher A Mol Pharmacol; 1998 Oct; 54(4):663-70. PubMed ID: 9765509 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia. Kitada S; Zapata JM; Andreeff M; Reed JC Blood; 2000 Jul; 96(2):393-7. PubMed ID: 10887097 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial damage and apoptosis in human leukemia cells (U937) overexpressing bcl-2 by the kinase inhibitor 7-hydroxystaurosporine (UCN-01). Tang L; Boise LH; Dent P; Grant S Biochem Pharmacol; 2000 Nov; 60(10):1445-56. PubMed ID: 11020446 [TBL] [Abstract][Full Text] [Related]
12. Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells. Harvey S; Decker R; Dai Y; Schaefer G; Tang L; Kramer L; Dent P; Grant S Clin Cancer Res; 2001 Feb; 7(2):320-30. PubMed ID: 11234887 [TBL] [Abstract][Full Text] [Related]
13. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation. Akiyama T; Sugiyama K; Shimizu M; Tamaoki T; Akinaga S Jpn J Cancer Res; 1999 Dec; 90(12):1364-72. PubMed ID: 10665655 [TBL] [Abstract][Full Text] [Related]
14. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism. Cartee L; Sankala H; Davis C; Smith R; Maggio S; Lin PS; Dent P; Grant S Int J Oncol; 2002 Aug; 21(2):351-9. PubMed ID: 12118331 [TBL] [Abstract][Full Text] [Related]
15. Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells. Akinaga S; Nomura K; Gomi K; Okabe M Cancer Chemother Pharmacol; 1994; 33(4):273-80. PubMed ID: 7506638 [TBL] [Abstract][Full Text] [Related]
16. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2. Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780 [TBL] [Abstract][Full Text] [Related]
17. UCN-01 (7-hydroxystaurosporine) inhibits the growth of human breast cancer xenografts through disruption of signal transduction. Koh J; Kubota T; Migita T; Abe S; Hashimoto M; Hosoda Y; Kitajima M Breast Cancer; 2002; 9(1):50-4. PubMed ID: 12196722 [TBL] [Abstract][Full Text] [Related]
18. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C. Takahashi I; Kobayashi E; Nakano H; Murakata C; Saitoh H; Suzuki K; Tamaoki T J Pharmacol Exp Ther; 1990 Dec; 255(3):1218-21. PubMed ID: 2262903 [TBL] [Abstract][Full Text] [Related]
19. UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice. Redkar AA; Meadows GG; Daoud SS Int J Oncol; 2001 Jul; 19(1):193-9. PubMed ID: 11408942 [TBL] [Abstract][Full Text] [Related]
20. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms. Wang S; Wang Z; Grant S Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]